Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 crore

Posted on:
Key Points

"The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity shares of Rs 21- each, constituting about 33.38% of the paid-up equity share capital of Unichem Laboratories, a listed entity, from one of its promoter shareholders at a price of Rs 440/- per equity share aggregating to Rs 1034.06 crore," Ipca said in an exchange filing...

This proposed acquisition is subject to the approval of the Competition Commission of India, the company said...

"The board of directors of the company also approved making an open offer to the public shareholders of Unichem Laboratories to acquire from them upto 26% of the fully diluted outstanding equity share capital of the said company at Rs 440/- per share aggregating to Rs 805.44 crore," the company said...

You might be interested in

PG Capital offloads 11.25% in Landmarks Cars for Rs 293 crore

23, Jun, 23

A host of entities picked up shares in the company such as Goldman Sachs, Societe Generale, Unifi Capital, Abakkus Asset Manager LLP, 3P India Equity Fund 1 and ICICI Prudential.

Bharti Airtel to allot 38.6 lakh equity shares to certain FCCB holders

02, Feb, 24

India Business News: Bharti Airtel will allot 38.6 lakh equity shares at Rs 518 per share to certain FCCB holders, increasing the company's paid-up equity share capital. T

Rategain Travel Tech raises ₹600 crore via qualified institutional buyers at ₹643 per share

20, Nov, 23

Rategain Travel Technologies, on November 20, said that the company has raised over ₹600 crore from qualified institutional buyers (QIBs) placement of shares.

SpiceJet share price rises over 5% on fundraising plans; check details

13, Jul, 23

SpiceJet's share price rose over 5% after its promoter, Ajay Singh, offered to invest ₹500 crore to improve the airline's financial status and raise new capital.

IOC announces Rs 22,000-cr rights issue

07, Jul, 23

The government, which is the majority owner of the company, is likely to subscribe to the rights issue and infuse equity in the company

Concord Biotech Limited’s IPO to open on August, 4, sets price band at Rs 705 to Rs 741 per equity share

01, Aug, 23

India Business News: Ahmedabad-based Concord Biotech Limited, a biotechnology company and one of the leading global developers and manufacturers of select fermentation-bas.